Clorox CLX
$104.73 −$0.17 (-0.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $104.58 -0.15%
Open$105.95
Prev close$104.90
Day range$104.68 – $107.81
Volume3.05M
Market cap$12.69B
P/E (TTM)18.9
Dividend yield4.75%
Fundamentals
Latest reported quarter: Q1, ended Sep 2026
Revenue$1.91B+33.3% YoY
Operating profit$249.00M+107.5% YoY
Net profit$173.00M+111.0% YoY
Diluted EPS$1.39+113.8% YoY
Free cash flow$105.00M+84.2% YoY
Operating cash flow$143.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin41.9%
Operating margin14.1%
Net margin9.4%
Return on assets10.1%
Current ratio0.65
Liabilities / assets98.5%
Cash & investments$184.00M
Total debt$5.51B
Net cash (debt)-$5.32B
Free cash flow / sales6.3%
Where the revenue comes from
Quarter 2027/Q1
By business line
Income statement
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.91B | $6.72B | $1.95B | $1.67B | $1.67B |
| Total Operating Revenue | $1.91B | $6.72B | $1.95B | $1.67B | $1.67B |
| Cost of Revenue | $1.14B | $3.88B | $1.14B | $948.00M | $951.00M |
| Gross Profit | $770.00M | $2.84B | $804.00M | $722.00M | $722.00M |
| Operating Expense | $521.00M | $1.96B | $558.00M | $438.00M | $486.00M |
| Selling and Admin Expenses | $480.00M | $1.82B | $514.00M | $406.00M | $452.00M |
| -Selling & Marketing Expense | $190.00M | $749.00M | $216.00M | $177.00M | $190.00M |
| -General & Admin Expense | $290.00M | $1.07B | $298.00M | $229.00M | $262.00M |
| Research & Development | $29.00M | $116.00M | $32.00M | $27.00M | $29.00M |
| Depreciation & Amortization & Depletion | $12.00M | $27.00M | $12.00M | $5.00M | $5.00M |
| -Depreciation & Amortization | $12.00M | $27.00M | $12.00M | $5.00M | $5.00M |
| Operating Profit | $249.00M | $886.00M | $246.00M | $284.00M | $236.00M |
| Net Non-Operating Interest Income (Expense) | -$51.00M | -$122.00M | -$54.00M | -$23.00M | -$24.00M |
| Non-Operating Interest Income | $1.00M | $8.00M | $1.00M | $4.00M | $1.00M |
| Non-Operating Interest Expense | $52.00M | $130.00M | $55.00M | $27.00M | $25.00M |
| Other Income (Expense) | $9.00M | $27.00M | $21.00M | -$5.00M | $3.00M |
| Gain on Sale of Security | -$1.00M | $21.00M | $15.00M | -$5.00M | $3.00M |
| Earnings from Equity Interest | $1.00M | $3.00M | $1.00M | $0.00 | $1.00M |
| Other Non-Operating Income (Expenses) | $9.00M | $3.00M | $5.00M | – | -$1.00M |
| Pretax Profit | $207.00M | $791.00M | $213.00M | $256.00M | $215.00M |
| Tax | $34.00M | $190.00M | $46.00M | $65.00M | $54.00M |
| Net Profit | $173.00M | $601.00M | $167.00M | $191.00M | $161.00M |
| Profit from Continuing Operations | $173.00M | $601.00M | $167.00M | $191.00M | $161.00M |
| Minority Interests | $3.00M | $14.00M | $4.00M | $4.00M | $4.00M |
| Net Income to Parent Company | $170.00M | $587.00M | $163.00M | $187.00M | $157.00M |
| Net Income to Common Stockholders | $170.00M | $587.00M | $163.00M | $187.00M | $157.00M |
| Basic EPS | $1.39 | $4.82 | $1.34 | $1.54 | $1.29 |
| Diluted EPS | $1.39 | $4.81 | $1.34 | $1.54 | $1.29 |
| Dividend Per Share | $1.25 | $4.96 | $1.24 | $1.24 | $1.24 |
| Special Income (Charges) | – | $0.00 | $0.00 | $0.00 | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | – | $0.00 | – | – | – |
| -Gain on Sale Of Business | – | $0.00 | $0.00 | $0.00 | $0.00 |
| -Gain on Sale of Property/Plant/Equipment | – | $0.00 | – | – | – |
Balance sheet
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Assets | $7.83B | $7.79B | $7.79B | $6.44B | $5.61B |
| Total Current Assets | $1.93B | $1.82B | $1.82B | $2.65B | $1.73B |
| Cash and Cash Equivalents & Short-Term Investments | $184.00M | $143.00M | $143.00M | $1.19B | $227.00M |
| -Cash and Cash Equivalents | $184.00M | $143.00M | $143.00M | $1.19B | $227.00M |
| Receivables | $745.00M | $791.00M | $791.00M | $671.00M | $671.00M |
| -Accounts Receivable | $745.00M | $769.00M | $769.00M | $671.00M | $671.00M |
| Inventory | $774.00M | $777.00M | $777.00M | $588.00M | $608.00M |
| Other Current Assets | $228.00M | $113.00M | $113.00M | $205.00M | $222.00M |
| Total Non-Current Assets | $5.90B | $5.97B | $5.97B | $3.79B | $3.89B |
| Net PPE | $1.87B | $1.91B | $1.91B | $1.59B | $1.62B |
| -Gross PPE | $4.99B | $5.01B | $5.01B | $4.63B | $4.62B |
| -Accumulated Depreciation | -$3.12B | -$3.10B | -$3.10B | -$3.04B | -$3.01B |
| Goodwill and Other Intangible Assets | $3.53B | $3.54B | $3.54B | $1.78B | $1.79B |
| -Goodwill | $1.94B | $1.95B | $1.95B | $1.23B | $1.23B |
| -Other Intangible Assets | $1.58B | $1.60B | $1.60B | $551.00M | $556.00M |
| Other Non-Current Assets | $510.00M | $517.00M | $517.00M | $415.00M | $483.00M |
| Total Liabilities | $7.71B | $7.54B | $7.54B | $6.34B | $5.58B |
| Total Current Liabilities | $2.95B | $2.77B | $2.77B | $3.16B | $2.35B |
| Short-Term Debt and Capital Lease Obligation | $1.27B | $1.17B | $1.17B | $1.68B | $390.00M |
| -Current Debt | $1.18B | $1.09B | $1.09B | $1.59B | $307.00M |
| -Current Capital Lease Obligation | $89.00M | $86.00M | $86.00M | $85.00M | $83.00M |
| Total Non-Current Liabilities | $4.76B | $4.77B | $4.77B | $3.19B | $3.23B |
| Long Term Debt and Capital Lease Obligation | $4.33B | $4.35B | $4.35B | $2.81B | $2.83B |
| -Long Term Debt | $3.98B | $3.98B | $3.98B | $2.49B | $2.49B |
| -Long Term Capital Lease Obligation | $347.00M | $366.00M | $366.00M | $323.00M | $341.00M |
| Non-Current Deferred Liabilities | $16.00M | $17.00M | $17.00M | $23.00M | $19.00M |
| Other Non-Current Liabilities | $412.00M | $71.00M | $71.00M | $356.00M | $385.00M |
| Total Equity | $121.00M | $252.00M | $252.00M | $92.00M | $35.00M |
| Stockholders' Equity | -$39.00M | $90.00M | $90.00M | -$67.00M | -$125.00M |
| Capital Stock | $131.00M | $131.00M | $131.00M | $131.00M | $131.00M |
| -Common Stock | $131.00M | $131.00M | $131.00M | $131.00M | $131.00M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.32B | $1.31B | $1.31B | $1.32B | $1.30B |
| Retained Earnings | $247.00M | $386.00M | $386.00M | $223.00M | $190.00M |
| Less: Treasury Stock | -$1.58B | -$1.58B | -$1.58B | -$1.58B | -$1.59B |
| Gains/Losses Not Affecting Retained Earnings | -$158.00M | -$157.00M | -$157.00M | -$152.00M | -$159.00M |
| Minority Interests | $160.00M | $162.00M | $162.00M | $159.00M | $160.00M |
| -Other Receivables | – | $22.00M | $22.00M | – | – |
| Payables | – | $1.02B | $1.02B | $1.48B | $1.96B |
| -Accounts Payable | – | $996.00M | $996.00M | $1.48B | $1.96B |
| -Dividends Payable | – | $28.00M | $28.00M | – | – |
| Current Accrued Expenses | – | $380.00M | $380.00M | – | – |
| Long Term Accounts Payable and Other Payables | – | $38.00M | $38.00M | – | – |
| Non-Current Liabilities | – | $25.00M | $25.00M | – | – |
| Employee Benefits | – | $271.00M | $271.00M | – | – |
Cash flow
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | $143.00M | $612.00M | $330.00M | -$122.00M | $311.00M |
| Net cash flow from continuing operations | $143.00M | $612.00M | $330.00M | -$122.00M | $311.00M |
| Net Income from Continuing Operations | $173.00M | $601.00M | $167.00M | $191.00M | $161.00M |
| Depreciation & Depletion & Amortization | $74.00M | $247.00M | $78.00M | $58.00M | $55.00M |
| Deferred Tax | $21.00M | $81.00M | -$54.00M | $43.00M | $8.00M |
| Other Non-Cash Items | $4.00M | -$483.00M | -$465.00M | -$2.00M | -$4.00M |
| Change in Working Capital | -$138.00M | $118.00M | $129.00M | $49.00M | $67.00M |
| -Change in Receivables | $42.00M | $151.00M | -$7.00M | $2.00M | $38.00M |
| -Change in Inventory | -$4.00M | -$71.00M | -$7.00M | $19.00M | -$28.00M |
| -Change in Prepaid Assets | -$44.00M | $2.00M | $16.00M | $16.00M | $11.00M |
| -Change in Payables and Accrued Expense | -$68.00M | $38.00M | $50.00M | -$6.00M | $34.00M |
| -Change In Other Working Capital | -$64.00M | -$2.00M | $77.00M | $18.00M | $12.00M |
| Net cash flow from investing | -$35.00M | -$2.30B | -$2.18B | -$43.00M | -$43.00M |
| Net Cash Flow from Continuing Investing Activities | -$35.00M | -$2.30B | -$2.18B | -$43.00M | -$43.00M |
| Capital Expenditure | -$38.00M | -$207.00M | -$86.00M | -$43.00M | -$42.00M |
| Net Other Investing Changes | $3.00M | $10.00M | $9.00M | $0.00 | -$1.00M |
| Financing Cash Flow | -$68.00M | $1.67B | $811.00M | $1.13B | -$210.00M |
| Net Cash Flow from Continuing Financing Activities | -$68.00M | $1.67B | $811.00M | $1.13B | -$210.00M |
| Net Issuance Payments Of Debt | $89.00M | $2.57B | $984.00M | $1.28B | $89.00M |
| Net Common Stock Issuance | $0.00 | -$256.00M | $0.00 | $0.00 | -$127.00M |
| Cash Dividends Paid | -$151.00M | -$602.00M | -$150.00M | -$150.00M | -$151.00M |
| Proceeds from Stock Option Exercised | -$6.00M | -$23.00M | -$7.00M | -$2.00M | -$21.00M |
| Ending Cash Balance | $187.00M | $147.00M | $147.00M | $1.19B | $229.00M |
| Net Change in Cash | $40.00M | -$21.00M | -$1.04B | $961.00M | – |
| Beginning Cash Balance | $147.00M | $170.00M | $1.19B | $229.00M | $169.00M |
| Effect of Exchange Rate Changes | $0.00 | -$2.00M | $0.00 | -$3.00M | $2.00M |
| Free Cash Flow | $105.00M | $405.00M | $244.00M | -$165.00M | $269.00M |
| Net Business Purchase and Sale | – | -$2.10B | -$2.10B | $0.00 | $0.00 |
| Net Other Financing Charges | – | -$16.00M | – | – | – |
No comments yet — be the first to weigh in on CLX.
Sign in to join the discussion.